The multiple antibiotic resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) has become a major clinical problem worldwide. The key determinant of the broad-spectrum beta-lactam resistance in MRSA strains is the penicillin-binding protein 2a (PBP2a). SCIPAC offer affinity purified monoclonal antibodies specific to PBP2a.
| Variant Name | Product Code | Purity | |
|---|---|---|---|
+ |
PBP2a (MRSA) mAb clone K7D9 | BM306-K7D9 | |
+ |
PBP2a (MRSA) mAb clone K9B4 | BM306-K9B4 | |
+ |
PBP2a (MRSA) mAb clone M3D1 | BM306-M3D1 | |
+ |
PBP2a (MRSA) mAb clone S6G8 | BM306-S6G8 | |
+ |
PBP2a (MRSA) mAb clone O3G7 | BM306-O3G7 | |